Literature DB >> 12401701

Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?

C N Sternberg1.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12401701     DOI: 10.1093/annonc/mdf670

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials.

Authors:  Michelle Boyar; Daniel P Petrylak
Journal:  Curr Oncol Rep       Date:  2005-05       Impact factor: 5.075

2.  Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.

Authors:  David C Johnson; Matthew E Nielsen; Jonathan Matthews; Michael E Woods; Eric M Wallen; Raj S Pruthi; Matthew I Milowsky; Angela B Smith
Journal:  BJU Int       Date:  2014-03-14       Impact factor: 5.588

3.  Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.

Authors:  Do Kyung Kim; Joo Yong Lee; Jae Hung Jung; Yoon Soo Hah; Kang Su Cho
Journal:  Investig Clin Urol       Date:  2019-01-31

Review 4.  Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.

Authors:  M D Michaelson; W U Shipley; N M Heney; A L Zietman; D S Kaufman
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.